Part 3/7:
The COVID-19 pandemic has exposed the gaps in traditional testing methods, emphasizing the urgent need for rapid, widespread testing. Currently, the United States has tested roughly 1% of its population—a figure far too low to effectively contain the virus. In response, Silicon Valley-based diagnostics company BillionToOne has announced a groundbreaking development: a highly sensitive COVID-19 test capable of processing up to one million samples per day.